Two Years After Albrecht's Death, FDA Forces "Mental Health Events" Chantix Warning
Categories: News
 |
Since then we've posted myriad updates on the U.S. Food and Drug Administration's investigations into Chantix and its effect on users, but none lately. Not until today: The FDA now says Chantix will now come with a warning that will "highlight the risk of serious mental health events including changes in behavior, depressed mood, hostility, and suicidal thoughts when taking these drugs." And, as The New York Times reminds, it took Carter's death and "a cascade of similar reports" -- including "98 reports of completed suicides and 188 reports of attempted suicides among those taking Chantix" -- to finally force the FDA's hand.
Email to Friend
Write to Editor
Print Article
